Skip to main content

sec filings

Insider trades

Open-market buys and sales that company insiders report to the SEC on .

Side
Planned sales
Role
QNRX

Updated 10/6/2026, 8:26 AM ET.

QNRX

Quoin Pharmaceuticals, Ltd.

Buy$99,991

Carter Denise P.

Chief Operating Officer, Director

20,490 shat $4.88Filed Sep 1, 9:40 PM ETFiling
QNRX

Quoin Pharmaceuticals, Ltd.

Buy$99,991

Myers Michael

Chief Executive Officer, Director

20,490 shat $4.88Filed Sep 1, 9:39 PM ETFiling
QNRX

Quoin Pharmaceuticals, Ltd.

Buy$49,991

Lawlor Sally Bridget

Chief Financial Officer

10,244 shat $4.88Filed Sep 1, 9:39 PM ETFiling
QNRX

Quoin Pharmaceuticals, Ltd.

Buy$29,992

Culverwell Anthony James

Director

6,146 shat $4.88Filed Sep 1, 9:38 PM ETFiling

Read from public SEC filings. Not financial advice.